Table 1 Baseline characteristics of study participants
Variables | Total, n = 99 |
|---|---|
Male, n (%) | 66 (66.7) |
Median age, years (interquartile range) | 67 (60–74) |
Median BMI, kg/m2 (interquartile range) | 21.6 (18.8–23.7) |
Median HD vintage, years (interquartile range) | 11 (6–19) |
Median systolic blood pressure, mmHg (interquartile range) | 137 (120–158) |
Median diastolic blood pressure, mmHg (interquartile range) | 72 (66–83) |
Primary cause of end-stage renal disease, n (%) | |
DMN | 24 (24.2) |
GN | 46 (46.5) |
HN | 8 (8.1) |
PKD | 6 (6.1) |
Others | 15 (15.2) |
Smoking (past, current) | 58 (58.6) |
Alcohol | 19 (19.2) |
Denture | 50 (50.5) |
More education than high school | 67 (67.7) |
More than 30 min of exercise, days per week | 4 (0–7) |
Comorbidities, n (%) | |
Diabetes | 32 (32.3) |
Stroke | 7 (7.1) |
Myocardial infarction | 15 (15.2) |
Amputation | 2 (2.0) |
Femoral neck fracture | 5 (5.2) |
Laboratory data | |
Median BUN, mg/dL (interquartile range) | 54.7 (47.7–64.8) |
Median creatinine, mg/dL (interquartile range) | 11.1 (9.3–12.8) |
Median hemoglobin, g/dL (interquartile range) | 11.2 (10.6–11.8) |
Median sodium, mEq/L (interquartile range) | 139 (137–141) |
Median phosphorus, mg/dL (interquartile range) | 4.8 (4.2–5.3) |
Median phosphorus, mg/dL (interquartile range) | 4.8 (4.1–5.8) |
Median zinc, μg/dL (interquartile range) | 52 (46–59) |
Median calcium, mg/dL (interquartile range) | 8.6 (7.8–9.1) |
Median albumin, g/dL (interquartile range) | 3.4 (3.2–3.7) |
Median β2 microglobulin, mg/L (interquartile range) | 28.4 (25.6–31.5) |
Medication, n (%) | |
RAS inhibitor | 24 (24.2) |
Diuretics | 13 (13.1) |
Calcium channel blocker | 47 (47.5) |
Β-blocker | 22 (22.2) |
Statin | 19 (19.2) |
Vitamin D | 36 (36.4) |
Proton pump inhibitor | 46 (46.5) |
H2 blocker | 9 (9.1) |
Sleep inducer | 13 (13.1) |
Chinese herbal medicine | 48 (48.5) |
NSAIDs | 4 (4.0) |